The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

McDermott Will & Emery LLP

THE MCDERMOTT BUILDING, 500 NORTH CAPITOL STREET, NW, WASHINGTON, DC 20001-1531, USA
Tel:
Work +1 202 756 8000
Fax:
Fax +1 202 756 8087
Email:
Web:
www.mwe.com

Vernessa Pollard

Tel:
Work +1 202 756 8181
Email:
Web:
www.mwe.com
McDermott Will & Emery LLP

Work Department

Health

Position

Partner

Career

Partner Vernessa T. Pollard advises companies on regulatory, compliance, enforcement and policy matters involving pharmaceuticals, medical devices, health information technology (HIT) and digital health solutions, services and software. She advises companies and investors on regulatory and compliance issues arising from mergers, acquisitions and other transactions involving Food and Drug Administration (FDA)-regulated products. She also counsels manufacturers, distributors and retailers on regulatory and compliance issues related to food and cosmetic marketing and safety.

Please visit McDermott's website for full biography.
https://www.mwe.com/en/team/p/pollard-vernessa


United States: Industry focus

Healthcare: life sciences

Within: Healthcare: life sciences

McDermott Will & Emery LLP's patent litigators William (Bill) Gaede in Silicon Valley and Sarah Columbia in Boston have been acting for Amgen in a patent lawsuit brought by the client against Sanofi and Regeneron and alleging the defendants’ patent infringement of Amgen’s patents to antibody therapies designed to lower cholesterol. The client base also includes 23andMe and Allergan. Other key members of the team are Chicago-based Kristian Werling, who co-heads the practice with Boston’s Stephen Bernstein; Washington DC-based Paul Radensky, who specializes in regulatory and reimbursement matters; IP and commercial transactions expert Sarah Hogan in Boston; FDA regulatory practitioner Vernessa Pollard in Washington DC; and Roger Kuan from the San Francisco office, which was opened in March 2018.

[back to top]


Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to